The Future of Myeloma Treatment: What’s Next?
March 10, 2025
Topics Covered
We invite you to learn more about:
- Current myeloma treatments
- What the future holds for myeloma treatment
- Side-effect management
Program Materials
Transcript will be available soon.
Speaker
C. Ola Landgren, MD, PhD
Professor of Medicine
Chief, Division of Myeloma, Department of Medicine
Director, Sylvester Myeloma Institute
Co-Leader, Translational and Clinical Oncology Program
Paul J. DiMare Endowed Chair in Immunotherapy
Sylvester Comprehensive Cancer Center
University of Miami
Miami, FL
Program Support
Support for this program provided by AbbVie Inc.; Genentech, a member of the Roche Group; GSK plc; Johnson & Johnson; and Sanofi.